ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

0
Player Avatar pchop123 (76.60) Submitted: 10/2/2012 8:21:12 PM : Outperform Start Price: $13.21 ISIS Score: +1.24

good hunch

Featured Broker Partners


Advertisement